All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Is evaluation of cortisol after dexamethasone suppression test enough? Analysis of steroid profile after dexamethasone suppression test using tandem mass spectrometry

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085962" target="_blank" >RIV/00023001:_____/25:00085962 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/25:10501594 RIV/00064165:_____/25:10501594

  • Result on the web

    <a href="https://ec.bioscientifica.com/view/journals/ec/14/9/EC-25-0281.xml" target="_blank" >https://ec.bioscientifica.com/view/journals/ec/14/9/EC-25-0281.xml</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1530/EC-25-0281" target="_blank" >10.1530/EC-25-0281</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Is evaluation of cortisol after dexamethasone suppression test enough? Analysis of steroid profile after dexamethasone suppression test using tandem mass spectrometry

  • Original language description

    Introduction The overnight dexamethasone suppression test (DST) is recommended for the initial testing of Cushing&apos;s syndrome. Simultaneous measurement of dexamethasone and cortisol is recommended. This study aimed to determine the cutoff value for dexamethasone measured in DST analyzed via liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) and to assess whether analysis of adrenal steroids other than cortisol may improve diagnostic accuracy. Methods A prospective study was conducted including patients with adrenal incidentalomas (n = 55), pituitary incidentalomas and symptoms of Cushing&apos;s disease (n = 18), and healthy controls (n = 100) undergoing DST. Plasma levels of ten steroids and dexamethasone were determined via 2D-LC-MS/MS, while cortisol levels were also determined via a chemiluminescence immunoassay. Results The lower 2.5th percentile of plasma dexamethasone in the control group (cortisol level &lt;50 nmol/L) was 3.48 nmol/L, which was set as the cutoff. In the subgroup of patients with adrenal incidentalomas, regardless of the results of DST, subjects exhibited identical changes in the basal adrenal steroid profile: increased 11-deoxycortisol and decreased DHEA and DHEAS levels. After 1 mg dexamethasone administration, cortisol and cortisone levels increased, while decreased androstenedione and 17-OHP levels were detected. Statistically significant changes were found in the subgroup of patients with pituitary incidentalomas: increased levels of 11-deoxycortisol, plasma cortisol, cortisone, and androstenedione were observed only in those with serum cortisol levels &gt;50 nmol/L. Based on the ROC curves, none of the steroid hormones exhibited higher specificity than cortisol. Conclusion Simultaneous measurement of cortisol and dexamethasone increases DST specificity. The cutoff value for dexamethasone was set at 3.48 nmol/L. None of the adrenal steroids in the DST demonstrated increased specificity; thus, a cortisol concentration &lt;50 nmol/L remains the gold standard for ruling out Cushing&apos;s syndrome.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Endocrine Connections

  • ISSN

    2049-3614

  • e-ISSN

    2049-3614

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    9

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    11

  • Pages from-to

    "art. no. e250281"

  • UT code for WoS article

    001614836500011

  • EID of the result in the Scopus database

    2-s2.0-105016153438